Jonathan Sporn

An Open-Label Trial of Riluzole in Patients With Treatment-Resistant Major Depression

Carlos A. Zarate, Jennifer L. Payne, Jorge A. Quiroz et al. · American Journal of Psychiatry · 2004 · 326 citations

Medicine, Pharmacotherapy, Psychiatry +17

Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells.

Bijay Mukherji, Nitya G. Chakraborty, Seiji Yamasaki et al. · Proceedings of the National Academy of Sciences · 1995 · 325 citations · Full text

Life Sciences, Immunology, Oncology +17

CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice

Renzo Mancuso, Gemma Fryatt, Juliane Obst et al. · Brain · 2019 · 240 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

β-Adrenergic Receptor Involvement in 6-Hydroxydopamine-Induced Supersensitivity in Rat Cerebral Cortex

Jonathan Sporn, K T., Barry B. Wolfe et al. · Science · 1976 · 238 citations

Life Sciences, Neuroscience, Pharmacology +15

New-Onset Diabetes Mellitus and Diabetic Ketoacidosis Associated With Olanzapine Treatment

Lee E. Goldstein, Jonathan Sporn, Susan Brown et al. · Psychosomatics · 1999 · 223 citations

Medicine, Pharmacology, Pharmacotherapy +16